StockDuty ← Dashboard Nov 10, 2026 05:35 PM ET
SignalEarnings

$DHR (DANAHER CORP /DE/) — 8-K: DHR Q3 FY26: Adj EPS $2.11 beats street by $0.19 (+10.0%) on $6.55B revenue

DHR
$233.02
+0.37%
Adjusted EPS of $2.11 topped the $1.92 consensus by $0.19, a 10.0% beat. Revenue came in at $6,554M, up 8.3% YoY, with core revenue up 3.0% and core ex-respiratory up 5.5%. Management raised FY2026 adjusted EPS guidance to $8.57–$8.62 from $8.45–$8.60 and guided Q4 FY26 adjusted operating margin to 29.5%. The print was fueled by accelerating core growth ex-respiratory plus DBS-driven execution, though respiratory testing was a 2.5% core headwind in the quarter.
Adjusted EPS of $2.11 topped the $1.92 consensus by $0.19, a 10.0% beat. Revenue came in at $6,554M, up 8.3% YoY, with core revenue up 3.0% and core ex-respiratory up 5.5%. Management raised FY2026 ad
Sources